Sudarshan Anand

3.1k total citations
44 papers, 2.3k citations indexed

About

Sudarshan Anand is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sudarshan Anand has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Sudarshan Anand's work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (6 papers). Sudarshan Anand is often cited by papers focused on MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (6 papers). Sudarshan Anand collaborates with scholars based in United States, Canada and Japan. Sudarshan Anand's co-authors include David A. Cheresh, Sara M. Weis, Miller Huang, Eric A. Murphy, David J. Shields, Lieping Chen, Bharat K. Majeti, Lisette M. Acevedo, Jeffrey N. Lindquist and Rajesh Mukthavaram and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Sudarshan Anand

42 papers receiving 2.3k citations

Peers

Sudarshan Anand
Minji Jo United States
Jae Hong Im United Kingdom
Mehdi Nosrati United States
Abdel Hosein United States
Christopher L. Tinkle United States
Minji Jo United States
Sudarshan Anand
Citations per year, relative to Sudarshan Anand Sudarshan Anand (= 1×) peers Minji Jo

Countries citing papers authored by Sudarshan Anand

Since Specialization
Citations

This map shows the geographic impact of Sudarshan Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudarshan Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudarshan Anand more than expected).

Fields of papers citing papers by Sudarshan Anand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudarshan Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudarshan Anand. The network helps show where Sudarshan Anand may publish in the future.

Co-authorship network of co-authors of Sudarshan Anand

This figure shows the co-authorship network connecting the top 25 collaborators of Sudarshan Anand. A scholar is included among the top collaborators of Sudarshan Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudarshan Anand. Sudarshan Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eide, Christopher A., Stephen E. Kurtz, Andy Kaempf, et al.. (2025). A rapid gene expression profiler predicts tumor responsiveness and patient outcome for standard-of-care therapies in acute myeloid leukemia. Blood. 146(Supplement 1). 657–657.
2.
Anand, Sudarshan, et al.. (2023). Immunomodulatory roles of PARPs: Shaping the tumor microenvironment, one ADP-ribose at a time. Current Opinion in Chemical Biology. 77. 102402–102402. 10 indexed citations
3.
Anand, Sudarshan, Ivy H. Gardner, Thomas J. Sharpton, et al.. (2022). Dietary and lifestyle associations with microbiome diversity. Gut Pathogens. 14(1). 49–49. 3 indexed citations
4.
Nelson, Dylan, et al.. (2022). A Cell-Based Screen Identifies HDAC Inhibitors as Activators of RIG-I Signaling. Frontiers in Molecular Biosciences. 9. 837610–837610. 2 indexed citations
5.
Gardner, Ivy H., Elizabeth N. Dewey, Rebecca Ruhl, et al.. (2021). A Distinct Innate Immune Signature of Early Onset Colorectal Cancer. ImmunoHorizons. 5(6). 489–499. 21 indexed citations
6.
Ruhl, Rebecca, Shushan Rana, Katherine A. Kelley, et al.. (2018). microRNA-451a regulates colorectal cancer proliferation in response to radiation. BMC Cancer. 18(1). 517–517. 31 indexed citations
7.
Schmid, Michael C., Samia Q. Khan, Megan M. Kaneda, et al.. (2018). Integrin CD11b activation drives anti-tumor innate immunity. Nature Communications. 9(1). 5379–5379. 197 indexed citations
8.
Zarour, Luai, Sudarshan Anand, Kevin G. Billingsley, et al.. (2017). Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions. Cellular and Molecular Gastroenterology and Hepatology. 3(2). 163–173. 198 indexed citations
9.
Kelley, Katherine A., Rebecca Ruhl, Shushan Rana, et al.. (2017). Understanding and Resetting Radiation Sensitivity in Rectal Cancer. Annals of Surgery. 266(4). 610–616. 16 indexed citations
10.
Espinosa‐Díez, Cristina, Namita Chatterjee, Rebecca Ruhl, et al.. (2016). MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nature. 18 indexed citations
11.
Advani, Sunil J., Maria F. Camargo, Laetitia Seguin, et al.. (2015). Kinase-independent role for CRAF-driving tumour radioresistance via CHK2. Nature Communications. 6(1). 8154–8154. 35 indexed citations
12.
Seguin, Laetitia, Shumei Kato, Aleksandra Franovic, et al.. (2014). An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition. Nature Cell Biology. 16(5). 457–468. 298 indexed citations
13.
Sakoda, Yukimi, Sudarshan Anand, Yuming Zhao, et al.. (2011). Herpesvirus entry mediator regulates hypoxia-inducible factor–1α and erythropoiesis in mice. Journal of Clinical Investigation. 121(12). 4810–4819. 10 indexed citations
14.
Huang, Miller, Sudarshan Anand, Jay S. Desgrosellier, et al.. (2011). EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation. Oncogene. 31(22). 2783–2793. 57 indexed citations
15.
Anand, Sudarshan, Yuming Zhao, Yumiko Matsumura, et al.. (2011). Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory. Cancer Immunology Immunotherapy. 61(2). 203–214. 13 indexed citations
16.
Mielgo, Ainhoa, Laetitia Seguin, Miller Huang, et al.. (2011). A MEK-independent role for CRAF in mitosis and tumor progression. Nature Medicine. 17(12). 1641–1645. 54 indexed citations
17.
Anand, Sudarshan & David A. Cheresh. (2011). Emerging Role of Micro-RNAs in the Regulation of Angiogenesis. Genes & Cancer. 2(12). 1134–1138. 35 indexed citations
18.
Park, Jang‐June, Ryusuke Omiya, Yumiko Matsumura, et al.. (2010). B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood. 116(8). 1291–1298. 266 indexed citations
19.
Anand, Sudarshan, Bharat K. Majeti, Lisette M. Acevedo, et al.. (2010). MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16(8). 909–914. 418 indexed citations
20.
Zhu, Gefeng, Mathew M. Augustine, Takeshi Azuma, et al.. (2008). B7-H4–deficient mice display augmented neutrophil-mediated innate immunity. Blood. 113(8). 1759–1767. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026